Overview

Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients

Status:
NOT_YET_RECRUITING
Trial end date:
2027-11-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of different doses of SYHX1901 tablets in the treatment of severe alopecia areata.
Phase:
PHASE2
Details
Lead Sponsor:
CSPC Ouyi Pharmaceutical Co., Ltd.
Collaborator:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.